Anticoagulant Therapy with the Oral Direct Factor Xa Inhibitors Rivaroxaban, Apixaban and Edoxaban and the Thrombin Inhibitor Dabigatran Etexilate in Patients with Hepatic Impairment
Jochen Graff, Sebastian HarderVolume:
52
Language:
english
DOI:
10.1007/s40262-013-0034-0
Date:
April, 2013
File:
PDF, 456 KB
english, 2013